Dr. Robert Allen Vescio MD Hematologist

Dr. Robert Vescio is a hematologist in Los Angeles, California. He is affiliated with multiple hospitals in the area, including Cedars-Sinai Medical Center and Ronald Reagan University of California Los Angeles Medical Center. He received his medical degree from UC San Diego School of Medicine and has been in practice for 28 years. He is one of 35 doctors at Cedars-Sinai Medical Center and one of 60 at Ronald Reagan University of California Los Angeles Medical Center who specialize in Hematology.

Are you Dr. Robert Vescio? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Cedars-Sinai Medical Center
Ranked #26 in Cancer

Ronald Reagan University of California Los Angeles Medical Center
Ranked #11 in Cancer

Education & Medical Training

University of California at San Diego
Residency, Internal Medicine, 1986 - 1989

UCLA Medical Center
Fellowship, Hematology, 1990 - 1993

UC San Diego School of Medicine
Class of 1986

Certifications & Licensure

American Board of Internal Medicine
Certified in Gastroenterology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Transplant Hepatology

AZ State Medical License
Active through 2014

Publications & Presentations

A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
Berenson, J. R.,Hilger, J. D.,Yellin, O.,Boccia, R. V.,Matous, J.,Dressler, K.,Ghazal, H. H.,Jamshed, S.,Kingsley, E. C.,Harb, W. A.,Noga, S. J.,Nassir, Y.,Swift, R. A.,Vescio, R.

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study.
Reece, D. E., Hegenbart, U., Sanchorawala, V., Merlini, G., Palladini, G., Bladé, J., Fermand, J. P., Hassoun, H., Heffner, L., Vescio, R. A., Liu, K., Enny, C., Esseltine, D. L., van de Velde, H., Cakana, A., Comenzo, R. L.

Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Berenson, J.R., Yang, H.H., Sadler, K., Jarutirasarn, S.G., Vescio, R.A., Mapes, R., Purner, M., Lee, S., Wilson, J., Morrison, B., Adams, J., Schenkein, D., Swift, R.

See all 74 publications

Insurances Accepted

  • Aetna Choice POS II
  • First Health PPO
  • Great West PPO
  • HealthLink PPO
  • Lovelace Health Plan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.